Braingels
Braingels is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Braingels.
Braingels is a company.
Key people at Braingels.
Key people at Braingels.
Braingels is an international angel investor network focused on early-stage braintech startups, launched by Israel Brain Technologies (IBT) to connect innovators with investors across neuroscience, neurotechnology, pharma, devices, digital therapeutics, and consumer applications.[2][4] It operates as a dynamic community of innovators, investors, and thought leaders, fostering investments in neurotechnology, AI, and mental health to accelerate breakthroughs from lab to market.[3] Unlike traditional VC firms, Braingels emphasizes a collaborative network model that bridges startups with specialized angels, enhancing the braintech startup ecosystem by providing targeted funding and expertise in high-impact areas like mental health and human flourishing.[2][3][4]
Braingels emerged from Israel Brain Technologies (IBT), a hub for braintech innovation, as part of the "Brainnovations" initiative announced in a 2018 PR release to propel brain technologies forward.[4] IBT launched Braingels as its flagship international investor network program, specifically designed to link early-stage braintech startups with global angels interested in neuroscience advancements.[2][4] Key figures include prominent members like Dr. Amy Kruse, who leads Satori Neuro (a fund targeting mental health and neurotech), Marine (focused on affordable mental health innovations and novel economic models), and serial entrepreneurs with exits to eBay and Facebook, alongside NVIDIA AI accelerator alumni.[3] Early traction stemmed from IBT's ecosystem, positioning Braingels to unearth and fund "dormant powerful ideas" in brain science.[1][3]
Braingels rides the explosive growth in neurotechnology and AI-driven brain health, a sector undergoing a "transformative step change" comparable to the human genome sequencing, fueled by advances in devices, digital therapeutics, and mental health solutions amid rising global demand.[1] Timing is ideal as brain science faces funding vulnerabilities, with market forces like AI integration, post-pandemic mental health crises, and institutional investor interest creating tailwinds for specialized networks.[1][3] By channeling angel capital into early-stage braintech, Braingels influences the ecosystem much like IBT's launchpads, de-risking translation from research to products and attracting talent/funding to underserved areas, ultimately boosting innovation in human wellbeing.[1][2][4]
Braingels is poised to scale as neurotech matures, potentially expanding its network amid surging AI-neuro intersections and demand for mental health tech, with members like Satori Neuro signaling deeper institutional plays.[3] Trends like affordable brain interventions, data-driven platforms, and public-private collaborations will shape its trajectory, amplifying its role in funding the next wave of human flourishing startups.[1][3] Its influence could evolve from niche connector to a cornerstone of global braintech, much like its origins with IBT—driving orders-of-magnitude progress in a field ripe for ecosystem-led acceleration.[1][2]
